Although many studies have been focused on roles of YB1 in the occurrence, development and treatment of malignant tumors, there is no research to investigate the relationship between the expression of YB1 and malignant phenotype as well as clinicopathological features for patients with NPC. The gene discussed is YBX1; the disease is cancer.